St. Barnabas' Hospital (Osaka)

Oova, Inc.'s Study Harnesses Hormone Data and Age to Precisely Determine Cycle Day within the Menstrual Cycle

Retrieved on: 
Thursday, August 3, 2023

NEW YORK, Aug. 3, 2023  /PRNewswire-PRWeb/ -- Oova, Inc. is proud to announce the publication of its latest groundbreaking study in MDPI journal, Medicina, titled "Using Hormone Data and Age to Pinpoint Cycle Day within the Menstrual Cycle." Conducted by esteemed scientists and co-authors, led by Dr. Amy Divaraniya, PhD founder of Oova, Inc., Dr. Mark B. Woodland, MD, Chair of Obstetrics and Gynecology at Tower Health, and Elinor Hills, content and brand lead at Oova, Inc, their discoveries bring a new understanding of the female reproductive cycle, particularly women with irregular periods, and confirms just how advanced and accurate remote hormone tracking has become.

Key Points: 
  • NEW YORK, Aug. 3, 2023 /PRNewswire-PRWeb/ -- Oova, Inc. is proud to announce the publication of its latest groundbreaking study in MDPI journal, Medicina, titled " Using Hormone Data and Age to Pinpoint Cycle Day within the Menstrual Cycle ."
  • Adding to Oova's extensive collection of research and data on women's hormone levels, the study challenges the standard norms used for comparison and disproves the assumption of a 28-day reproductive cycle.
  • In this study, the Oova team evaluated hormone data from 4,123 cycles across 1,233 users, analyzing and tracking the LH and PdG via urine tests throughout menstrual cycles across different age groups.
  • Using Oova's hormone data to train their algorithm, Oova can now determine a woman's cycle day based on her age and hormone levels with 95% confidence.